Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hoenigl, M; Eigl, S; Heldt, S; Duettmann, W; Thornton, C; Prattes, J.
Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis.
Mycoses. 2018; 61(1):40-43
Doi: 10.1111/myc.12704
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Hönigl Martin
- Prattes Jürgen
- Co-Autor*innen der Med Uni Graz
- Düttmann Wiebke
- Eigl Susanne
- Heldt Sven
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The study evaluated the newly formatted Aspergillus-specific lateral-flow-device (LFD), and compared its performance to the original prototype "old" LFD test using BALF samples from 28 patients (14 patients with probable/proven invasive pulmonary aspergillosis [IPA] and 14 patients with no evidence for IPA). A total of 10/14 (71%) of BALF samples from patients with probable/proven IPA resulted positive with the new LFD, including 8/9 with true-positive and 2/5 with false-negative results with the old LFD. All 14 samples from patients without IPA resulted negative with the new LFD; specificity of the new LFD was significantly improved compared to the old LFD. © 2017 Blackwell Verlag GmbH.
- Find related publications in this database (using NLM MeSH Indexing)
- Bronchoalveolar Lavage Fluid - microbiology
- Case-Control Studies -
- Chromatography, Affinity - instrumentation
- Chromatography, Affinity - methods
- Female -
- Humans -
- Intensive Care Units - statistics & numerical data
- Invasive Pulmonary Aspergillosis - diagnosis
- Invasive Pulmonary Aspergillosis - immunology
- Invasive Pulmonary Aspergillosis - microbiology
- Male -
- Mannans - immunology
- Middle Aged -
- Point-of-Care Systems -
- Prospective Studies -
- Sensitivity and Specificity -
- Find related publications in this database (Keywords)
- bronchoalveolar lavage
- galactomannan
- Haematological malignancy
- intensive care unit
- point-of-care